Published in Best Pract Res Clin Rheumatol on October 01, 2010
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells. Nat Med (2012) 4.38
The balance of tissue repair and remodeling in chronic arthritis. Nat Rev Rheumatol (2011) 1.24
Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther (2012) 1.20
[Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course]. Z Rheumatol (2011) 0.75
Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med (2008) 3.89
Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum (2007) 2.45
Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med (2009) 2.32
The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol (2010) 2.21
A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. Arthritis Rheum (2010) 2.02
Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum (2006) 2.01
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) (2009) 2.00
Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol (2003) 1.99
Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. Ann Rheum Dis (2010) 1.75
Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res (2003) 1.75
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest (2005) 1.73
Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum (2003) 1.67
Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum (2007) 1.61
Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther (2012) 1.52
Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells (2012) 1.49
Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis. Am J Hum Genet (2008) 1.45
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther (2009) 1.42
Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years. J Rheumatol (2004) 1.42
Failure of in vitro-differentiated mesenchymal stem cells from the synovial membrane to form ectopic stable cartilage in vivo. Arthritis Rheum (2004) 1.34
Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: early treatment matters. Am J Sports Med (2011) 1.31
Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci U S A (2012) 1.28
Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part I: from three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev (2009) 1.26
Cartilage repair: past and future--lessons for regenerative medicine. J Cell Mol Med (2009) 1.24
Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther (2012) 1.20
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis (2014) 1.17
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis (2012) 1.15
Donor site morbidity after articular cartilage repair procedures: a review. Acta Orthop Belg (2010) 1.14
Quantification of lung fibrosis and emphysema in mice using automated micro-computed tomography. PLoS One (2012) 1.14
The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice. Ann Rheum Dis (2007) 1.14
Biological aspects of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2011) 1.13
Contemporary concepts of inflammation, damage and repair in rheumatic diseases. Best Pract Res Clin Rheumatol (2006) 1.13
Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant (2010) 1.13
Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev (2005) 1.11
Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis. Arthritis Rheum (2006) 1.07
Bcl11a is required for neuronal morphogenesis and sensory circuit formation in dorsal spinal cord development. Development (2012) 1.07
GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis (2010) 1.07
The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials (2011) 1.07
A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum (2008) 1.06
Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc (2009) 1.06
The Noggin null mouse phenotype is strain dependent and haploinsufficiency leads to skeletal defects. Dev Dyn (2006) 1.06
Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp Cell Res (2003) 1.04
Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol (2009) 1.03
Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med (2011) 1.03
Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res (2003) 1.01
Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone. Arthritis Rheum (2007) 1.01
Xenopus SMOC-1 Inhibits bone morphogenetic protein signaling downstream of receptor binding and is essential for postgastrulation development in Xenopus. J Biol Chem (2009) 1.00
Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng (2006) 0.98
Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng Part A (2011) 0.98
Investigating the genetic association between ERAP1 and spondyloarthritis. Ann Rheum Dis (2012) 0.95
Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials (2012) 0.95
Gait characteristics and lower limb muscle strength in women with early and established knee osteoarthritis. Clin Biomech (Bristol, Avon) (2012) 0.93
Noggin null allele mice exhibit a microform of holoprosencephaly. Hum Mol Genet (2011) 0.92
Dependence on interferon-gamma for the spontaneous occurrence of arthritis in DBA/1 mice. Arthritis Rheum (2003) 0.92
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med (2013) 0.91
Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. Biomaterials (2012) 0.90
Proprioceptive accuracy in women with early and established knee osteoarthritis and its relation to functional ability, postural control, and muscle strength. Clin Rheumatol (2013) 0.89
Expansion of murine periosteal progenitor cells with fibroblast growth factor 2 reveals an intrinsic endochondral ossification program mediated by bone morphogenetic protein 2. Stem Cells (2014) 0.88
Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study. Osteoporos Int (2004) 0.88
Structure of NPP1, an ectonucleotide pyrophosphatase/phosphodiesterase involved in tissue calcification. Structure (2012) 0.87
Validation of a PicoGreen-based DNA quantification integrated in an RNA extraction method for two-dimensional and three-dimensional cell cultures. Tissue Eng Part C Methods (2012) 0.86
Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells. Stem Cell Res (2011) 0.86
Physical activity levels after characterized chondrocyte implantation versus microfracture in the knee and the relationship to objective functional outcome with 2-year follow-up. Am J Sports Med (2009) 0.86
Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors. Biomaterials (2013) 0.86
Characterization and optimization of cell seeding in scaffolds by factorial design: quality by design approach for skeletal tissue engineering. Tissue Eng Part C Methods (2011) 0.86
Bone morphogenetic proteins in destructive and remodeling arthritis. Arthritis Res Ther (2007) 0.86
White paper on how to go forward with cell-based advanced therapies in Europe. Tissue Eng Part A (2014) 0.86
Mechanisms of pathologic new bone formation. Curr Rheumatol Rep (2006) 0.86
A semi-autonomous model of endochondral ossification for developmental tissue engineering. Tissue Eng Part A (2012) 0.86
Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritis. Arthritis Res Ther (2010) 0.85
Functional effects of susceptibility genes in osteoarthritis. Discov Med (2011) 0.85
An N-terminal G11A mutation in HOXD13 causes synpolydactyly and interferes with Gli3R function during limb pre-patterning. Hum Mol Genet (2012) 0.85
Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? Curr Rheumatol Rep (2012) 0.85
Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo. Ann Rheum Dis (2011) 0.84
Developmental engineering: a new paradigm for the design and manufacturing of cell-based products. Part II: from genes to networks: tissue engineering from the viewpoint of systems biology and network science. Tissue Eng Part B Rev (2009) 0.84
Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease. Arthritis Res Ther (2008) 0.83
Process quality engineering for bioreactor-driven manufacturing of tissue-engineered constructs for bone regeneration. Tissue Eng Part C Methods (2013) 0.83
Spatial optimization in perfusion bioreactors improves bone tissue-engineered construct quality attributes. Biotechnol Bioeng (2014) 0.83
Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol (2007) 0.82
Variation at the ANP32A gene is associated with risk of hip osteoarthritis in women. Arthritis Rheum (2009) 0.82
Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis. Rheumatology (Oxford) (2012) 0.82
Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity. Expert Opin Biol Ther (2014) 0.82
Implementing one standardized rehabilitation protocol following autologous chondrocyte implantation or microfracture in the knee results in comparable physical therapy management. Physiother Theory Pract (2010) 0.82
Activation of cartilage-derived morphogenetic protein-1 in torn rotator cuff. Clin Orthop Relat Res (2002) 0.81
Three-dimensional characterization of tissue-engineered constructs by contrast-enhanced nanofocus computed tomography. Tissue Eng Part C Methods (2013) 0.81
Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities. J Bone Miner Res (2012) 0.81
High inter-specimen variability of baseline data for the tibio-talar contact area. Clin Biomech (Bristol, Avon) (2008) 0.80
delta-EF1 is a negative regulator of Ihh in the developing growth plate. J Cell Biol (2009) 0.80
Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development. Gene Expr Patterns (2003) 0.80
Anti-TNF therapy and malignancy in spondyloarthritis in the Leuven spondyloarthritis biologics cohort (BIOSPAR). Clin Exp Rheumatol (2013) 0.79
Bone morphogenetic protein signaling and arthritis. Cytokine Growth Factor Rev (2009) 0.79
Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C Methods (2008) 0.79
Relating the chondrocyte gene network to growth plate morphology: from genes to phenotype. PLoS One (2012) 0.79
Characterization of Frzb-Cre transgenic mouse. Genesis (2004) 0.79
Osteoimmunology: Wnt antagonists: for better or worse? Nat Rev Rheumatol (2009) 0.79
Skeletal tissue regeneration: where can hydrogels play a role? Int Orthop (2014) 0.78
A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement. JMIR Mhealth Uhealth (2016) 0.78
Destructive dural ectasia of dorsal and lumbar spine with cauda equina syndrome in a patient with ankylosing spondylitis. Open Rheumatol J (2010) 0.78